优宁维(301166)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301166 优宁维

已收盘 07-18 15:00:00

{"stockData":{"symbol":"301166","market":"SZ","secType":"STK","nameCN":"优宁维","latestPrice":26.11,"timestamp":1721286216000,"preClose":26.15,"halted":0,"volume":416200,"delay":0,"floatShares":41268900,"shares":86666700,"eps":0.3185,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.04,"latestTime":"07-18 15:00:00","open":26.25,"high":26.25,"low":25.55,"amount":10795700,"amplitude":0.0268,"askPrice":26.19,"askSize":3,"bidPrice":26.11,"bidSize":18,"shortable":0,"etf":0,"ttmEps":0.3185,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721352600000},"adr":0,"adjPreClose":26.15,"symbolType":"stock","openAndCloseTimeList":[[1721266200000,1721273400000],[1721278800000,1721286000000]],"highLimit":28.77,"lowLimit":23.54,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":86666668,"pbRate":1.07,"roa":"--","roe":"0.02%","epsLYR":0.47,"committee":0.065574,"marketValue":2263000000,"floatMarketCap":1078000000,"peRate":81.978019,"changeRate":-0.0015,"turnoverRate":0.0101,"status":1},"requestUrl":"/m/hq/s/301166","defaultTab":"news","newsList":[{"id":"2451619339","title":"优宁维：南京优宁维承建的“南京生物制剂生产线建设项目”尚处于建设过程中，目前处于建设后期","url":"https://stock-news.laohu8.com/highlight/detail?id=2451619339","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451619339?lang=zh_cn&edition=full","pubTime":"2024-07-15 17:04","pubTimestamp":1721034247,"startTime":"0","endTime":"0","summary":"证券之星消息，优宁维07月15日在投资者关系平台上答复投资者关心的问题。南京优宁维承建的“南京生物制剂生产线建设项目”尚处于建设过程中，目前处于建设后期。项目建设进程可关注公司后续披露的相关公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071500022778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2449400853","title":"千金藤素概念盘中拉升，优宁维涨1.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449400853","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449400853?lang=zh_cn&edition=full","pubTime":"2024-07-05 09:44","pubTimestamp":1720143873,"startTime":"0","endTime":"0","summary":"07月05日，千金藤素概念盘中拉升，截至09点44分，千金藤素概念整体指数上涨0.54%，报703.200点。从个股上来看，该概念的成分股中，优宁维涨1.54%，方盛制药、理邦仪器、皓元医药涨幅居前。从资金上来看，截止发稿，千金藤素概念主力净流入为-538.61万，其中皓元医药受到资金热捧，主力净流入70.17万；拉长时间线来看，该板块近20日主力资金净流入-4.20亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705094433941f402e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705094433941f402e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0250","688131","301166","BK0216"],"gpt_icon":0},{"id":"2448933176","title":"优宁维（301166）6月28日主力资金净买入202.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448933176","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448933176?lang=zh_cn&edition=full","pubTime":"2024-07-01 09:22","pubTimestamp":1719796920,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年6月28日收盘，优宁维报收于27.0元，下跌2.42%，换手率2.65%，成交量1.09万手，成交额3005.99万元。近5日资金流向一览见下表：优宁维融资融券信息显示，融资方面，当日融资买入523.61万元，融资偿还180.13万元，融资净买入343.49万元。优宁维主营业务：公司面向高等院校、科研院所、医院和生物医药企业等,提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070100003709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2446321814","title":"优宁维（301166）6月26日主力资金净卖出281.07万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446321814","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446321814?lang=zh_cn&edition=full","pubTime":"2024-06-27 09:13","pubTimestamp":1719450791,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年6月26日收盘，优宁维报收于28.52元，上涨7.7%，换手率5.1%，成交量2.1万手，成交额6054.36万元。近5日资金流向一览见下表：优宁维融资融券信息显示，融资方面，当日融资买入430.69万元，融资偿还631.97万元，融资净偿还201.29万元。优宁维主营业务：公司面向高等院校、科研院所、医院和生物医药企业等,提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062700013438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2446393528","title":"优宁维：6月25日高管冷兆文增持股份合计1000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446393528","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446393528?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:01","pubTimestamp":1719406897,"startTime":"0","endTime":"0","summary":"证券之星消息，根据6月26日市场公开信息、上市公司公告及交易所披露数据整理，优宁维最新董监高及相关人员股份变动情况：2024年6月25日公司董事冷兆文共增持公司股份1000.0股，占公司总股本为0.0012%。变动期间公司股价下跌0.3%，6月25日当日收盘报26.48元。优宁维近半年内的董监高及核心技术人员增减持详情如下：优宁维的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流入71.46万，融资余额增加；融券净流入200.0，融券余额增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062600042244.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2446830115","title":"优宁维（301166）6月24日主力资金净卖出34.42万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446830115","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446830115?lang=zh_cn&edition=full","pubTime":"2024-06-25 09:23","pubTimestamp":1719278597,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年6月24日收盘，优宁维报收于26.56元，下跌6.15%，换手率2.31%，成交量9543.0手，成交额2590.98万元。近5日资金流向一览见下表：优宁维融资融券信息显示，融资方面，当日融资买入436.2万元，融资偿还264.13万元，融资净买入172.07万元。优宁维主营业务：公司面向高等院校、科研院所、医院和生物医药企业等,提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062500010169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2445099001","title":"千金藤素概念盘中跳水，优宁维跌3.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445099001","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445099001?lang=zh_cn&edition=full","pubTime":"2024-06-24 09:39","pubTimestamp":1719193172,"startTime":"0","endTime":"0","summary":"06月24日，千金藤素概念盘中跳水，截至09点39分，千金藤素概念整体指数下跌0.59%，报736.840点。从个股上来看，该概念的成分股中，优宁维跌3.36%，步长制药、海王生物、理邦仪器跌幅居前。从资金上来看，截止发稿，千金藤素概念主力净流入为-298.28万，其中步长制药受到资金热捧，主力净流入328.89万；拉长时间线来看，该板块近20日主力资金净流入-3.67亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624093932aef62c77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624093932aef62c77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["301166","603858","BK0250","BK0196","BK0239"],"gpt_icon":0},{"id":"2445274171","title":"优宁维（301166）6月20日主力资金净卖出234.63万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445274171","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445274171?lang=zh_cn&edition=full","pubTime":"2024-06-21 09:12","pubTimestamp":1718932366,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年6月20日收盘，优宁维报收于28.09元，上涨1.85%，换手率3.72%，成交量1.53万手，成交额4350.8万元。近5日资金流向一览见下表：优宁维融资融券信息显示，融资方面，当日融资买入394.84万元，融资偿还474.08万元，融资净偿还79.24万元。优宁维主营业务：公司面向高等院校、科研院所、医院和生物医药企业等,提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062100015467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2440647884","title":"优宁维：基因测序技术的相关产品您可登录公司官网查询，华大基因是公司的生物医药企业类客户","url":"https://stock-news.laohu8.com/highlight/detail?id=2440647884","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440647884?lang=zh_cn&edition=full","pubTime":"2024-06-03 20:01","pubTimestamp":1717416079,"startTime":"0","endTime":"0","summary":"优宁维董秘：投资者您好，公司的研发产品和研发方向主要结合客户需求和市场热点开展，公司最新产品的研发及上架情况可关注公司官网或微信公众号。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060300026530.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300676","BK0046","301166","BK0042","BK0197","399441","161726","BK0221","BK0196","BK0250"],"gpt_icon":0},{"id":"2436994065","title":"优宁维(301166.SZ)拟10股派4.7元 于5月27日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2436994065","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436994065?lang=zh_cn&edition=full","pubTime":"2024-05-17 18:33","pubTimestamp":1715942025,"startTime":"0","endTime":"0","summary":"智通财经APP讯，优宁维(301166.SZ)公告，公司2023年度权益分派拟：向全体股东每10股派发现金股利4.7元(含税)。除权除息日为：2024年5月27日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1122696.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2435607323","title":"优宁维（301166）5月10日主力资金净卖出1059.89万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435607323","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435607323?lang=zh_cn&edition=full","pubTime":"2024-05-13 09:21","pubTimestamp":1715563304,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月10日收盘，优宁维报收于32.74元，下跌4.13%，换手率10.22%，成交量4.22万手，成交额1.43亿元。近5日资金流向一览见下表：优宁维融资融券信息显示，融资方面，当日融资买入1676.7万元，融资偿还1635.35万元，融资净买入41.36万元。优宁维主营业务：公司面向高等院校、科研院所、医院和生物医药企业等,提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051300001985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2434093745","title":"优宁维：5月9日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2434093745","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434093745?lang=zh_cn&edition=full","pubTime":"2024-05-09 19:16","pubTimestamp":1715253402,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年5月9日优宁维发布公告称公司于2024年5月9日召开业绩说明会。南京研发生产基地建设进展顺利，目前机电安装有序进行，预计今年投入使用。自募集资金于 2021年 12月到账以来，公司积极推进募投项目的实施。优宁维2024年一季报显示，公司主营收入2.72亿元，同比下降0.91%；归母净利润520.25万元，同比下降70.97%；扣非净利润35.75万元，同比下降96.66%；负债率10.25%，投资收益210.94万元，财务费用-347.91万元，毛利率19.25%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900034919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2434037270","title":"优宁维股东因违规交易被深圳证券交易所采取监管措施","url":"https://stock-news.laohu8.com/highlight/detail?id=2434037270","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434037270?lang=zh_cn&edition=full","pubTime":"2024-05-09 13:00","pubTimestamp":1715230840,"startTime":"0","endTime":"0","summary":"证券之星消息，5月8日优宁维公开信息显示，优宁维股东宁波保税区嘉信麒越股权投资管理有限公司-苏州上凯创业投资合伙企业，宁波嘉信佳禾创业投资合伙企业因违规交易被深圳证券交易所创业板公司管理部采取监管措施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900020881.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399001","BK0250","301166"],"gpt_icon":0},{"id":"2434003185","title":"优宁维股东减持违规 上市即巅峰超募13亿民生证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2434003185","media":"中国经济网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434003185?lang=zh_cn&edition=full","pubTime":"2024-05-09 11:16","pubTimestamp":1715224560,"startTime":"0","endTime":"0","summary":"　　本次变动后，嘉信投资和上凯投资合计持有优宁维股份3,911,968股，占优宁维总股本比例的4.52%。优宁维的保荐机构为民生证券股份有限公司，保荐代表人为梁军、卞进。　　上市次日，优宁维盘中创下股价最高点136元，此后股价震荡下跌。优宁维最终募集资金净额比原计划多13.12亿元。　　优宁维发行费用合计2.69亿元，民生证券股份有限公司获得承销及保荐费用2.48亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-05-09/doc-inauraup6392680.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-05-09/doc-inauraup6392680.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["161027","301166","BK0250"],"gpt_icon":0},{"id":"2434084392","title":"优宁维（301166）5月8日主力资金净买入1375.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434084392","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434084392?lang=zh_cn&edition=full","pubTime":"2024-05-09 09:10","pubTimestamp":1715217049,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年5月8日收盘，优宁维报收于36.89元，上涨14.07%，换手率18.83%，成交量7.77万手，成交额2.81亿元。近5日资金流向一览见下表：优宁维融资融券信息显示，融资方面，当日融资买入3000.05万元，融资偿还1360.05万元，融资净买入1640.0万元。优宁维主营业务：公司面向高等院校、科研院所、医院和生物医药企业等,提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900015054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"gpt_icon":0},{"id":"2433724958","title":"5月8日优宁维发布公告，其股东减持30.91万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433724958","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433724958?lang=zh_cn&edition=full","pubTime":"2024-05-08 22:01","pubTimestamp":1715176887,"startTime":"0","endTime":"0","summary":"证券之星消息，5月8日优宁维发布公告《优宁维:关于股东减持结果的公告》，其股东宁波保税区嘉信麒越股权投资管理有限公司-苏州上凯创业投资合伙企业、宁波嘉信佳禾创业投资合伙企业于2023年8月18日至2024年5月8日间合计减持30.91万股，占公司目前总股本的0.3567%，变动期间该股股价下跌15.41%，截止5月8日收盘报36.89元。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050800040092.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2433253397","title":"优宁维(301166.SZ)遭股东嘉信投资及上凯投资合计减持30.91万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2433253397","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433253397?lang=zh_cn&edition=full","pubTime":"2024-05-08 20:52","pubTimestamp":1715172742,"startTime":"0","endTime":"0","summary":"智通财经APP讯，优宁维(301166.SZ)公告，公司股东嘉信投资及上凯投资减持计划已期限届满，合计减持公司股份30.91万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1118987.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2430229853","title":"优宁维：公司对外投资收购，主要围绕现有主营业务，寻找具有协同效应的标的企业，以实现经营业绩不断提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2430229853","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430229853?lang=zh_cn&edition=full","pubTime":"2024-04-26 18:04","pubTimestamp":1714125861,"startTime":"0","endTime":"0","summary":"投资者：尊敬的董秘你好，从国际巨头的大型公司来说，要想成长做大做强必须进行产业并购，贵公司上市2年多了，融资了大量现金，迟迟不进行并购，是找不到合适的并购公司吗优宁维董秘：投资者您好，公司对外投资收购，主要围绕现有主营业务，寻找具有协同效应的标的企业，以实现经营业绩不断提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600044215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0},{"id":"2430249654","title":"优宁维(301166.SZ)发布一季度业绩，净利润520.25万元，下降70.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430249654","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430249654?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:07","pubTimestamp":1714118860,"startTime":"0","endTime":"0","summary":"智通财经APP讯，优宁维(301166.SZ)发布2024年第一季度报告，该公司营业收入为2.72亿元，同比减少0.91%。归属于上市公司股东的净利润为520.25万元，同比减少70.97%。归属于上市公司股东的扣除非经常性损益的净利润为35.75万元，同比减少96.66%。基本每股收益为0.06元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111432.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301166"],"gpt_icon":0},{"id":"2429125723","title":"优宁维（301166）2023年年报简析：增收不增利，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2429125723","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429125723?lang=zh_cn&edition=full","pubTime":"2024-04-24 06:23","pubTimestamp":1713911002,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期优宁维发布2023年年报。根据财报显示，本报告期中优宁维增收不增利，三费占比上升明显。截至本报告期末，公司营业总收入12.26亿元，同比上升2.57%，归母净利润4031.88万元，同比下降62.18%。筹资活动产生的现金流量净额变动幅度为-974.88%,原因:本期支付2022年度利润分配及归还银行贷款。证券之星价投圈财报分析工具显示：资产质量方面，公司现金资产非常健康。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400012297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-12-28","address":"上海市杨浦区控江路1690号1505室","stockEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.0414},{"period":"3month","weight":-0.0391},{"period":"6month","weight":-0.2038},{"period":"1year","weight":-0.3873},{"period":"ytd","weight":-0.3085}],"companyName":"上海优宁维生物科技股份有限公司","boardCode":"AI0051","perCapita":"3527股","boardName":"批发业","registeredCapital":"8666万元","compareEarnings":[{"period":"1week","weight":0.008},{"period":"1month","weight":-0.0176},{"period":"3month","weight":-0.0362},{"period":"6month","weight":0.0461},{"period":"1year","weight":-0.0735},{"period":"ytd","weight":-0.0041}],"survey":"　　上海优宁维生物科技股份有限公司是一家面向高等院校、科研院所、医院和生物医药企业等，提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务的科学服务商。公司主要产品及服务有生命科学试剂、生命科学仪器及耗材、综合技术服务。目前公司提供生命科学产品SKU约870万种，覆盖基因、蛋白、细胞、组织及动物等不同水平的研究对象，涵盖生命科学基础研究、医学基础研究、体外诊断研究、药物研发、细胞治疗研究等领域，是国内生命科学产品种类及规格最全面的供应商之一。","serverTime":1721302527857,"listedPrice":86.06,"stockholders":"11700人(较上一季度减少8.91%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"优宁维(301166)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供优宁维(301166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"优宁维,301166,优宁维股票,优宁维股票老虎,优宁维股票老虎国际,优宁维行情,优宁维股票行情,优宁维股价,优宁维股市,优宁维股票价格,优宁维股票交易,优宁维股票购买,优宁维股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"优宁维(301166)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供优宁维(301166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}